ITU Unit Action

RIABNI

Amgen Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	88182290	FILING DATE	11/05/2018
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	BUSH, KAREN K	L.O. ASSIGNED	108

PUB INFORMATION
RUN DATE	11/02/2020
PUB DATE	09/10/2019
STATUS	731-SECOND EXTENSION - GRANTED
STATUS DATE	10/29/2020
LITERAL MARK ELEMENT	RIABNI

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	YES
LITERAL MARK ELEMENT	RIABNI
MARK DRAWING CODE	4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Amgen Inc.
ADDRESS	Trademark Operations - MS-28-5A One Amgen Center Drive Thousand Oaks, CA 913201799
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

GOODS AND SERVICES
INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	005	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
10/31/2020	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	026
10/29/2020	EX2G	S	EXTENSION 2 GRANTED	025
10/29/2020	EXT2	S	EXTENSION 2 FILED	024
10/29/2020	EEXT	I	TEAS EXTENSION RECEIVED	023
04/30/2020	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	022
04/28/2020	EX1G	S	EXTENSION 1 GRANTED	021
04/28/2020	EXT1	S	EXTENSION 1 FILED	020
04/28/2020	EEXT	I	TEAS EXTENSION RECEIVED	019
11/05/2019	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	018
09/10/2019	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	017
09/10/2019	PUBO	A	PUBLISHED FOR OPPOSITION	016
08/21/2019	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	015
08/08/2019	ALIE	A	ASSIGNED TO LIE	014
07/29/2019	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	013
07/25/2019	XAEC	I	EXAMINER'S AMENDMENT ENTERED	012
07/25/2019	GNEN	O	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	011
07/25/2019	GNEA	O	EXAMINERS AMENDMENT E-MAILED	010
07/25/2019	CNEA	R	EXAMINERS AMENDMENT -WRITTEN	009
03/07/2019	ARAA	I	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	008
03/07/2019	REAP	I	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	007
12/13/2018	GPRN	O	NOTIFICATION OF PRIORITY ACTION E-MAILED	006
12/13/2018	GPRA	F	PRIORITY ACTION E-MAILED	005
12/13/2018	CPRA	R	PRIORITY ACTION WRITTEN	004
12/11/2018	DOCK	D	ASSIGNED TO EXAMINER	003
11/20/2018	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
11/08/2018	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Timothy J. Gaul
CORRESPONDENCE ADDRESS	Timothy J. Gaul Amgen Inc. Trademark Operations-MS-28-5A One Amgen Center Drive Thousand Oaks CA 91320-1799
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Amgen Inc.
ADDRESS	One Amgen Center Drive Thousand Oaks, CA 913201799
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

ITU Unit Action [image/jpeg]

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.